Minimal Residue Disease Testing Market Scope And Analysis

  • Report Code : TIPRE00039104
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Minimal Residue Disease Testing Market - Analysis 2031

Buy Now

Minimal Residue Disease Testing Market Report Minimal Residue Disease Testing Market Size and Share Minimal Residue Disease Testing Market Scope and Analysis

Minimal Residue Disease Testing Market Report Scope

Report Attribute Details
Market size in 2023 US$ 3.55 Billion
Market Size by 2031 US$ 8.94 Billion
Global CAGR (2023 - 2031) 12.24%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Technique
  • Flow Cytometry
  • PCR
  • NGS
By Cancer Type
  • Leukemia
  • Lymphoma
  • Solid Tumors
  • Multiple Myeloma
By End User
  • Hospitals
  • Specialty Clinics
  • Diagnostic Laboratories
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Rest of Asia Pacific
Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Rest of Europe
Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East and Africa
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Adaptive Biotechnologies
  • Natera
  • Bio Rad Laboratories
  • F Hoffmann La Roche Ltd
  • Guardant Health
  • LabCorp
  • Sysmex Corporation
  • ARUP Laboratories
  • Invivoscribe Inc
  • NeoGenomics Laboratories Inc